Evidence map›Paper›PMID 26928529›Full record

ArticleJournal of controlled release : official journal of the Controlled Release Society2016

Injectable polypeptide micelles that form radiation crosslinked hydrogels in situ for intratumoral radiotherapy.

Jeffrey L Schaal, Xinghai Li, Eric Mastria, Jayanta Bhattacharyya, Michael R Zalutsky, Ashutosh Chilkoti, Wenge Liu

Abstract read
In one paragraph

Article in Journal of controlled release : official journal of the Controlled Release Society, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
5.1field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 66 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. Review
  9. Review
  10. Review
  11. Review
  12. Brachytherapy via a depot of biopolymer-boundNature biomedical engineering · 2022
    Article
  13. Intratumoral delivery of brachytherapy and immunotherapy by a thermally triggered polypeptide depot.Journal of controlled release : official journal of the Controlled Release Society · 2022
    Article
  14. Peptide-based coacervates in therapeutic applications.Frontiers in bioengineering and biotechnology · 2022
    Review
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Jeffrey L SchaalDepartment of Biomedical Engineering, Duke University, Durham, NC 27708, USA.
Xinghai LiDepartment of Biomedical Engineering, Duke University, Durham, NC 27708, USA.
Eric MastriaDepartment of Biomedical Engineering, Duke University, Durham, NC 27708, USA.
Jayanta BhattacharyyaDepartment of Biomedical Engineering, Duke University, Durham, NC 27708, USA.
Michael R ZalutskyDepartment of Biomedical Engineering, Duke University, Durham, NC 27708, USA; Radiology, Duke University, Durham, NC 27708, USA.
Ashutosh ChilkotiDepartment of Biomedical Engineering, Duke University, Durham, NC 27708, USA. Electronic address: chilkoti@duke.edu.
Wenge LiuDepartment of Biomedical Engineering, Duke University, Durham, NC 27708, USA. Electronic address: wengeliu@duke.edu.
Duke University · US

Funding

Women's Cancer Research ProgramP30CA014236 · NCI · DUKE UNIVERSITY · PI DONNA NIEDZWIECKI · 1985 to 2026
$174.8M
Thermally Targeted Drug Delivery by Elastin BiopolymersR01EB000188 · NIBIB · DUKE UNIVERSITY · PI CHILKOTI, ASHUTOSH · 2002 to 2015
$3.9M
Thermally Triggered Multivalent Targeting of TumorsR01EB007205 · NIBIB · DUKE UNIVERSITY · PI CHILKOTI, ASHUTOSH · 2007 to 2015
$2.7M
Local Radionuclide Delivery to Solid Tumors by Injectible BiopolymerR01CA138784 · NCI · DUKE UNIVERSITY · PI LIU, WENGE · 2009 to 2014
$1.6M
NCI NIH HHS 5R01CA138784-03NCI NIH HHS NIH CA014236NCI NIH HHS P30 CA014236NCI NIH HHS R01 CA138784NIBIB NIH HHS R01 EB000188NIBIB NIH HHS R01EB000188NIBIB NIH HHS R01 EB007205NIBIB NIH HHS R01EB007205
6 · The paper itself

Abstract

Intratumoral radiation therapy - 'brachytherapy' - is a highly effective treatment for solid tumors, particularly prostate cancer. Current titanium seed implants, however, are permanent and are limited in clinical application to indolent malignancies of low- to intermediate-risk. Attempts to develop polymeric alternatives, however, have been plagued by poor retention and off-target toxicity due to degradation. Herein, we report on a new approach whereby thermally sensitive micelles composed of an elastin-like polypeptide (ELP) are labeled with the radionuclide (131)I to form an in situ hydrogel that is stabilized by two independent mechanisms: first, body heat triggers the radioactive ELP micelles to rapidly phase transition into an insoluble, viscous coacervate in under 2 min; second, the high energy β-emissions of (131)I further stabilize the depot by introducing crosslinks within the ELP depot over 24h. These injectable brachytherapy hydrogels were used to treat two aggressive orthotopic tumor models in athymic nude mice: a human PC-3 M-luc-C6 prostate tumor and a human BxPc3-luc2 pancreatic tumor model. The ELP depots retained greater than 52% and 70% of their radioactivity through 60 days in the prostate and pancreatic tumors with no appreciable radioactive accumulation (≤ 0.1% ID) in off-target tissues after 72h. The (131)I-ELP depots achieved >95% tumor regression in the prostate tumors (n=8); with a median survival of more than 60 days compared to 12 days for control mice. For the pancreatic tumors, ELP brachytherapy (n=6) induced significant growth inhibition (p=0.001, ANOVA) and enhanced median survival to 27 days over controls.

Indexed as

AnimalsBrachytherapyCell Line, TumorDelayed-Action PreparationsElastinHot TemperatureHumansHydrogelsInjectionsIodine RadioisotopesMaleMice, Inbred BALB CMicellesMice, NudePancreasPancreatic NeoplasmsDelayed-Action PreparationsElastinHydrogelsIodine RadioisotopesMicellesPeptidesElastin-like polypeptideHydrogelNanoparticlesPancreatic cancerProstate cancerRadiotherapy

Identifiers

PMID26928529
PMCPMC4828320
OpenAlexW2290903994

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.